I think you overestimate the "simple to do" part in terms of actually implementing human therapies, but, in any case, crop and industrial bacteria applications are further along toward commercialization now (some of the former may actually already be commercialized), while human therapies may be among the eventual applications, its quite unlikely (and maybe already passed into "impossible") that they will be the first profitable applications.